Moreover, exo-eIF4E RNA expression in late stage (III + IV) patients was significantly higher than that in early stage (I + II) patients, thus suggesting RNA expression of exo-eIF4E may correlate with cancer progression. The gene discussed is EIF4E; the disease is cancer.